This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development.
eLife · 2022
Latest funding
- $680,850
Role of fibronectin mutations in spondylometaphyseal dysplasia and idiopathic scoliosis.
CIHR · 2017 · Principal investigator
1 publications.
Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development.
Mead TJ, Martin DR, Wang LW, Cain SA, Gulec C, Cahill E, Mauch J, Reinhardt D, Lo C, Baldock C, Apte SS
Role of fibronectin mutations in spondylometaphyseal dysplasia and idiopathic scoliosis.
Principal investigators: Campeau, Philippe M; Reinhardt, Dieter P
Keywords: Fibronectin; Scoliosis; Skeletal Dysplasia
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.